CYP3A4 and CYP3A5 genotyping by Pyrosequencing - Wikidata - awgldk - TriplyDB

CYP3A4 and CYP3A5 genotyping by Pyrosequencing

CYP3A4 and CYP3A5 genotyping by Pyrosequencing

http://www.wikidata.org/entity/Q24810187

about

Genetic polymorphisms in MDR1, CYP3A4 and CYP3A5 genes in a Ghanaian population: a plausible explanation for altered metabolism of ivermectin in humans?Frequency and prognostic significant of CYP3A4-A-290G polymorphism in acute myeloid leukemia Pharmacogenetics in Ghana: reviewing the evidence.Pharmacogenomic Research in South Africa: Lessons Learned and Future Opportunities in the Rainbow Nation.Exploration of CYP450 and drug transporter genotypes and correlations with nevirapine exposure in Malawians Pharmacogenomic assessment of Mexican and Peruvian populations.Polymorphisms and phenotypic analysis of cytochrome P450 3A4 in the Uygur population in northwest China Distribution of human CYP2C8*2 allele in three different African populations Frequencies of genetic polymorphisms related to triptans metabolism in chronic migraine.CYP2C8*3 predicts benefit/risk profile in breast cancer patients receiving neoadjuvant paclitaxel.Distribution of genetic polymorphisms of genes encoding drug metabolizing enzymes & drug transporters - a review with Indian perspective.Optimizing the use of sunitinib in metastatic renal cell carcinoma: an update from clinical practice.CYP3A4*22: promising newly identified CYP3A4 variant allele for personalizing pharmacotherapy.Cytochrome P450 pharmacogenetics in African populations.Functional gene variants of CYP3A4.Genotyping of CYP3A5 polymorphisms among Bulgarian patients with sporadic colorectal cancer and controls.Cytochrome allelic variants and clopidogrel metabolism in cardiovascular diseases therapy.Systematic screening for CYP3A4 genetic polymorphisms in a Han Chinese population.Analysis of CYP3A4 genetic polymorphisms in Han Chinese.Global pharmacogenomics: distribution of CYP3A5 polymorphisms and phenotypes in the Brazilian population.Allele and genotype frequencies of the polymorphic cytochrome P450 genes (CYP1A1, CYP3A4, CYP3A5, CYP2C9 and CYP2C19) in the Jordanian population.Characterization of CYP1A2, CYP2C19, CYP3A4 and CYP3A5 polymorphisms in South Brazilians.Genetic variation at the tumour virus B locus in commercial and laboratory chicken populations assessed by a medium-throughput or a high-throughput assay.The effect of aprepitant and race on the pharmacokinetics of cyclophosphamide in breast cancer patients.Pharmacogenetically relevant polymorphisms in Portugal.SNPs associated with activity and toxicity of cabazitaxel in patients with advanced urothelial cell carcinoma.Significant impacts of CYP3A4*1G and CYP3A5*3 genetic polymorphisms on the pharmacokinetics of diltiazem and its main metabolites in Chinese adult kidney transplant patients.Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients Impact of population admixture on the distribution of theCYP3A5*3polymorphism Genetic Polymorphisms and the Impact of a Higher Clopidogrel Dose Regimen on Active Metabolite Exposure and Antiplatelet Response in Healthy Subjects

P2860

Q33632608-2EC70C6F-9DDD-436E-A187-601C81849496 Q34951945-05002236-1F3D-43ED-ACA9-75D9724307FE Q35172002-65C42A8B-E252-466D-92DF-51BF946F3277 Q35584999-5602793C-6BFB-4602-B5C3-251AAC3D9B40 Q35796733-BD4D0556-38B2-435B-A60F-76CAF410651D Q35890226-CD1BC164-32A4-404B-8EE2-08AB2B52910F Q35919286-0A120ECA-9C2D-4244-B9A6-83C80F3A22E3 Q35963368-18F40A2C-B8D1-4161-AF8B-FDE0650D331E Q36261201-48DC0431-AC1B-488E-8C02-13E316BB6448 Q37055326-6951237E-B3F1-49C2-A942-3CF296D03F9A Q37715233-D66FC035-39A4-4FE1-A7D5-44D9EF23F52C Q37760950-CC958BF3-F395-4A39-98A8-763EF9B91C28 Q38068539-8A6DEEA3-234C-4FA6-A746-135512D27F57 Q38099372-FE99E4AB-E171-4EA6-AF4E-3EB94DF385F0 Q38220008-3BA48963-5331-46C6-BD04-B99DDB86819A Q38429245-6140A137-0604-469F-9CF9-40BE0CF27CB5 Q38806725-12B57554-68ED-45FC-968B-25779C48C99C Q38937515-83A29152-E11B-4A29-80EF-EE38EE25C12D Q39575083-1A5223E1-D90C-4938-903A-D98E281B3EAC Q41774099-18F42BC1-B516-42BF-8C86-BD346F17BBD9 Q43759147-844E1B07-1E68-4A12-9E85-4AB02DFC5AA0 Q44502093-96B80966-8C5F-46FD-8BCB-0E177AF45D88 Q45402135-A7522B80-AB9E-46BB-9F11-1ACA419E38BA Q46608510-B4077030-AE49-4A16-9DE8-BB4504F71261 Q46778374-CE593614-B92B-4CFB-BE7E-4B528F86CA05 Q53135936-0C0913D4-BCFA-4C12-9A39-32279F0B457E Q54435691-4AFB1324-BBB1-41D2-A523-704967DF174F Q57163492-5759A95E-2315-406B-B33E-A484FB0FFCD6 Q57163787-6467D61A-C3BE-4F6B-8C5B-D072134161E6 Q58158894-D2C3B651-A7DF-4575-8067-0ED96915FBE3

P2860

CYP3A4 and CYP3A5 genotyping by Pyrosequencing

http://www.wikidata.org/entity/Q24810187

description

2005 nî lūn-bûn

@nan

2005 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

CYP3A4 and CYP3A5 genotyping by Pyrosequencing

@ast

CYP3A4 and CYP3A5 genotyping by Pyrosequencing

@en

CYP3A4 and CYP3A5 genotyping by Pyrosequencing

@nl

type

label

CYP3A4 and CYP3A5 genotyping by Pyrosequencing

@ast

CYP3A4 and CYP3A5 genotyping by Pyrosequencing

@en

CYP3A4 and CYP3A5 genotyping by Pyrosequencing

@nl

prefLabel

CYP3A4 and CYP3A5 genotyping by Pyrosequencing

@ast

CYP3A4 and CYP3A5 genotyping by Pyrosequencing

@en

CYP3A4 and CYP3A5 genotyping by Pyrosequencing

@nl

P1433

Q24810187-B5027DD4-F6B0-478E-950B-493A40346B39

P1476

Q24810187-949238DF-EDBA-4B87-A79C-73AC91D64C95

P2093

Q24810187-87B7EAF4-632B-4A87-8AF6-4955AFCE1BBD

Q24810187-9E4EE851-5806-4569-B786-D10988EEF6EE

Q24810187-FBC8FF9F-2DFD-4291-A7B9-AA1A86B9E126

P2860

Q24810187-0E860204-C567-4629-B5D3-4B936ADF04B4

Q24810187-1E0E3AF9-299B-4D17-8DB2-D814100E14BA

Q24810187-20467A59-BAA9-4717-8050-DDECDC4B8F1D

Q24810187-37EB980F-D07C-4883-B968-C543E750032C

Q24810187-417ECCBE-B969-42E6-B4C9-62701D3BDA8A

Q24810187-42E0355D-27EC-43A6-9BFD-ABDFFA05C2F9

Q24810187-4A7BF8B3-28E4-492C-BBD9-3378CFC85C88

Q24810187-5486085F-798C-4AC2-B78A-CEB41F2E0C31

Q24810187-5903791A-2814-4573-8133-F5120E7E7354

Q24810187-762A00F6-FB0C-4445-9E72-7B0D18B1086B

P2888

Q24810187-7D1C2C83-4329-4002-9AB3-AC698924E01E

P304

Q24810187-1276A720-3752-456A-89FE-62B75F2FBF93

P31

Q24810187-61DA5AB1-93EB-423E-B5CC-5AA6057EDAC3

P356

Q24810187-BDBCD1DD-5D7C-4698-B3CE-CDFB679E3BBB

P407

Q24810187-99048FA2-CA8C-400B-BBB0-0AEF36DDD5B2

P433

Q24810187-2DBB31AC-4B12-496E-B5A1-8611D44DBE40

P478

Q24810187-58C539E8-53FD-40AB-83FE-83DD66A3913C

P577

Q24810187-4AE46F95-3D44-4A7B-9845-4BCF977C7548

P5875

Q24810187-6F7A095A-26C0-45AF-9EC1-A9251FD2369C

P6179

Q24810187-CB6D3066-F993-495E-BA0D-6CEE8A3619FE

P698

Q24810187-AB1F89AB-CEB1-4435-B3E4-845199AD6C5C

P932

Q24810187-A789D60E-6570-44AE-90A5-DBC2B6CAA801

P356

P1433

BMC Medical Genetics

P1476

CYP3A4 and CYP3A5 genotyping by Pyrosequencing

@en

P2093

Adam A Garsa

http://www.w3.org/2001/XMLSchema#string

Howard L McLeod

http://www.w3.org/2001/XMLSchema#string

Sharon Marsh

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic contribution to variable human CYP3A-mediated metabolism

Efficient selective screening of haplotype tag SNPs.

Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.

Pharmacogenetic analysis of clinically relevant genetic polymorphisms.

Association of CYP3A4 genotype with treatment-related leukemia.

CYP3A4 allelic variants with amino acid substitutions in exons 7 and 12: evidence for an allelic variant with altered catalytic activity.

The human drug metabolizing cytochromes P450.

Association between a CYP3A4 genetic variant and clinical presentation in African-American prostate cancer patients.

Caution on pedigree haplotype inference with software that assumes linkage equilibrium.

Identification and functional characterization of eight CYP3A4 protein variants.

P2888

P304

19

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2350-6-19

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2005-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7859593

http://www.w3.org/2001/XMLSchema#string

P6179

1019250438

http://www.w3.org/2001/XMLSchema#string

P698

15882469

http://www.w3.org/2001/XMLSchema#string

P932

1142317

http://www.w3.org/2001/XMLSchema#string